Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1674-8018
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy ; day:8 ; month:6 ; year:2017 ; pages:1-16
Protein & cell ; (8.6.2017), 1-16
- Schlagwort
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Urheber
-
Mimura, Yusuke
- Beteiligte Personen und Organisationen
-
Katoh, Toshihiko
Saldova, Radka
O’Flaherty, Roisin
Izumi, Tomonori
Mimura-Kimura, Yuka
Utsunomiya, Toshiaki
Mizukami, Yoichi
Yamamoto, Kenji
Matsumoto, Tsuneo
Rudd, Pauline M.
SpringerLink (Online service)
- DOI
-
10.1007/s13238-017-0433-3
- URN
-
urn:nbn:de:1111-2017101417675
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mimura, Yusuke
- Katoh, Toshihiko
- Saldova, Radka
- O’Flaherty, Roisin
- Izumi, Tomonori
- Mimura-Kimura, Yuka
- Utsunomiya, Toshiaki
- Mizukami, Yoichi
- Yamamoto, Kenji
- Matsumoto, Tsuneo
- Rudd, Pauline M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
How to select IgG subclasses in developing anti-tumor therapeutic antibodies
Therapeutic antibodies
Therapeutic antibodies
Altered glycosylation profiles of serum IgG in Takayasu arteritis
Changes of serum IgG glycosylation patterns in rheumatoid arthritis
Development of differentially glycosylated IgG antibodies
Functionality-Enhanced Antibodies for Precision Cancer Therapy
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
MIgGGly (mouse IgG glycosylation analysis) - a high-throughput method for studying Fc-linked IgG N-glycosylation in mice with nanoUPLC-ESI-MS
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Optimal Synthetic Glycosylation of a Therapeutic Antibody
How to select IgG subclasses in developing anti-tumor therapeutic antibodies
Therapeutic antibodies
Therapeutic antibodies
Altered glycosylation profiles of serum IgG in Takayasu arteritis
Changes of serum IgG glycosylation patterns in rheumatoid arthritis
Development of differentially glycosylated IgG antibodies
Functionality-Enhanced Antibodies for Precision Cancer Therapy
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
MIgGGly (mouse IgG glycosylation analysis) - a high-throughput method for studying Fc-linked IgG N-glycosylation in mice with nanoUPLC-ESI-MS
Optimal Synthetic Glycosylation of a Therapeutic Antibody
Optimal Synthetic Glycosylation of a Therapeutic Antibody
How to select IgG subclasses in developing anti-tumor therapeutic antibodies
Therapeutic antibodies
Therapeutic antibodies
Altered glycosylation profiles of serum IgG in Takayasu arteritis
Changes of serum IgG glycosylation patterns in rheumatoid arthritis
Development of differentially glycosylated IgG antibodies
Functionality-Enhanced Antibodies for Precision Cancer Therapy
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
MIgGGly (mouse IgG glycosylation analysis) - a high-throughput method for studying Fc-linked IgG N-glycosylation in mice with nanoUPLC-ESI-MS
Optimal Synthetic Glycosylation of a Therapeutic Antibody